Source:http://linkedlifedata.com/resource/pubmed/id/20735223
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-8-25
|
pubmed:abstractText |
Nascent high-density lipoprotein (HDL) capable of intracellularly delivering anticancer drugs was developed to potentiate antitumor activities.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1748-6963
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
867-79
|
pubmed:meshHeading | |
pubmed:year |
2010
|
pubmed:articleTitle |
Intracellular drug delivery by genetically engineered high-density lipoprotein nanoparticles.
|
pubmed:affiliation |
Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|